Sprintec and Naproxen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sprintec (ethinyl estradiol; norgestimate) and Naproxen (naproxen). Common drug interactions include drug ineffective among females and premature baby among males.

The phase IV clinical study analyzes what interactions people have when they take Sprintec and Naproxen. It is created by eHealthMe based on reports of 46 people who take the same drugs from the FDA, and is updated regularly.

What is Sprintec?

Sprintec has active ingredients of ethinyl estradiol; norgestimate. It is often used in birth control. eHealthMe is studying from 4,397 Sprintec users. Check the latest studies of Sprintec.

What is Naproxen?

Naproxen has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 72,032 Naproxen users. Check the latest studies of Naproxen.



On Jul, 24, 2026

46 people who take Sprintec and Naproxen together, and have interactions are studied.

Sprintec and Naproxen drug interactions.

What are the common drug interactions of Sprintec and Naproxen, by gender? *:

female:

  1. Drug ineffective
  2. Abdominal discomfort
  3. Anxiety
  4. Chest pain
  5. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  6. Dehydration (dryness resulting from the removal of water)
  7. Dyspnoea (difficult or laboured respiration)
  8. Fatigue (feeling of tiredness)
  9. Gallbladder non-functioning
  10. Hunger

male:

  1. Premature baby

What are the common drug interactions of Sprintec and Naproxen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Abdominal pain
  2. Constipation

20-29:

  1. Dizziness
  2. Headache (pain in head)
  3. Nausea (feeling of having an urge to vomit)
  4. Chest pain
  5. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  6. Dyspnoea (difficult or laboured respiration)
  7. Gallbladder non-functioning
  8. Intervertebral disc protrusion (spinal disc protrusion)
  9. Nerve injury
  10. Peroneal nerve palsy

30-39:

  1. Hypersensitivity
  2. Insomnia (sleeplessness)
  3. Abasia (inability to walk)
  4. Injection site pain
  5. Ankylosing spondylitis (type of arthritis affecting the spine)
  6. Anxiety
  7. Depression
  8. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  9. Drug ineffective
  10. Eye swelling

40-49:

  1. Psoriasis (immune-mediated disease that affects the skin)
  2. Abdominal discomfort
  3. Fatigue (feeling of tiredness)
  4. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)

50-59:

  1. Bipolar disorder (mood disorder)
  2. Chronic kidney disease
  3. Hyperhidrosis (abnormally increased sweating)
  4. Overdose
  5. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  6. Weight increased

60+:

n/a

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 14 people, 30.43%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 13 people, 28.26%
  3. Psoriasis (immune-mediated disease that affects the skin): 7 people, 15.22%
  4. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 10.87%
  5. Drowsiness: 5 people, 10.87%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 8.70%
  7. Migraine (headache): 3 people, 6.52%

* Approximation only. Some reports may have incomplete information.

Do you take Sprintec and Naproxen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sprintec and Naproxen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sprintec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Naproxen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sprintec and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Naproxen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ethinyl estradiol; norgestimate and naproxen (the active ingredients of Sprintec and Naproxen, respectively), and Sprintec and Naproxen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: